Your browser doesn't support javascript.
loading
Autologous cellular therapy for myeloma: Giving ex vivo expanded NK cells their due.
Shapiro, Roman M; Romee, Rizwan.
Afiliación
  • Shapiro RM; Division of Cellular Therapy and Stem Cell Transplantation, Dana Farber Cancer Institute, Harvard Medical School.
  • Romee R; Division of Cellular Therapy and Stem Cell Transplantation, Dana Farber Cancer Institute, Harvard Medical School.
Cell Rep Med ; 3(2): 100537, 2022 02 15.
Article en En | MEDLINE | ID: mdl-35243428
ABSTRACT
Ex vivo feeder-free autologous NK cell expansion is an efficient modality for clinical translation. In this issue of Cell Reports Medicine, Nahi et al. describe the use of this approach as consolidation therapy for multiple myeloma,1 thereby reviving an alternate avenue for NK cell therapy.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mieloma Múltiple Límite: Humans Idioma: En Revista: Cell Rep Med Año: 2022 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mieloma Múltiple Límite: Humans Idioma: En Revista: Cell Rep Med Año: 2022 Tipo del documento: Article